![]() |
Technical Data |
|
022756 |
Varlitinib |
5mg |
| Biochemicals | Storage: RTShipping: RT |
|
Varlitinib is a tyrosine kinase inhibitor being developed for the treatment of cancer. Varlitinib acts by disrupting the receptor tyrosine kinases ErbB-2, ErbB-4 and EGFR. CAS Number: 845272-21-1 Molecular Formula: C22H19ClN6O2S Molecular Weight: 466.94 |
Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological. Toxicity and Hazards: All products should be handled by qualified personnel only, trained in laboratory procedures. |
|
Adiba et al.: Int. J. Pharm. Biol. Arch., 2, 1651 (2011); Li, D.-D. et al.: Curr. Med, Chem., 19, 871 (2012);
|
||